Samer E. Farah

Samer E. Farah, M.D.

Email

Phone

Location

  • 3250 Westchester Avenue Suite 320 Bronx, NY 10461


Selected Publications

Publications:

  • The Impact of Cataract Surgery on Pre-Exsisting Retinal Disease. Eye Net Spet 2010.

 

  • Treatment of subretinal neovascular membrane in a patient with membranoproliferative glomerulonephritis type II. Ophthalmic Surgery, Laser and Imaging, 2009 July/August:40(4):416-8

 

  • Treatemt of Neovascular Age Related Macular Degeneration With Pegaptanib and Boosting With Bevacizumab or Ranibizumab as Needed. Ophthalmic Surgery, Laser and Imaging, 2008 July-August:39(4):294-8

 

  • Prevalence of Retinopathy and Microalbuminuria in Pediatric Type 2 Diabetics. Journal of Pediatric Endocrinology, and Metabolisim, 19,937-942 (2006).

 

  • Ectopic Orbital Meningioma, a case report and a review of the literature.  Ophthalmologic Plastic and Reconstructive Surgery, 1999, November 15 (6) 463-6.

 

  • Immunohistochemistry of Infiltrating Lymphocytes in Uveal Malignant Melanoma. Investigative Ophthalmology & Visual Science, July 1993; Vol. 34, Number 8: 2603-26

Research:

  • Principle Investigator with Allergan for the Phase III Clinical trial of Dexamethasone Posterior Segment Drug delivery system in Branch and Central retinal Vein Occlusion.

 

  • Sub-investigator with Genentech for the phase III-b of Lucentis in macular degeneration

 

  • Part of a collaborative effort in the NY area with Columbia University to search for a possible gene for age-related macular degeneration.

 

  • Blood Coagulation in Diabetic Retinopathy, Rush University, Chicago Illinois, summer 1989

 

  • Efficacy of Combination Dilation Therapy vs. Multiple Single Drop Therapy. Presented at the Second Annual Ophthalmology Research Seminar, 2000.

                               Grants:

  • The Sarah Decoizart Article Five Perpetual Trust: For the purpose establishing a Diabetic retinopathy and retinal edema Center at Montefiore medical Center.

 

Consultant and on the Speaker Bureau:

  • Allergan,
  • Eyetech pharmacuticles